VolitionRx Limited announced the appointment of Dr. Phillip Barnes to the company's Board of Directors as a Non-Executive Director, effective October 9, 2019. Dr. Barnes was also appointed to the company's Audit, Compensation and Nominations and Governance Committees. As a non-executive member of the company's Board, Dr. Barnes will provide independent expertise and strategic counsel to VolitionRx in connection with the planned commercialization of its Nu.QTM blood-based diagnostic platform. Dr. Barnes served as Executive Medical Director on a number of hospital and Foundation Trust Boards until his retirement from the NHS in 2016.